RPG Life Sciences AGM: All resolutions passed, including dividend declaration.
RPG Life Sciences Limited's Nineteenth AGM on July 23, 2026, saw all resolutions passed. Key approvals include the FY26 financial statements, a ₹24 per share dividend, director re-appointments, and the appointment of Dr. Pratit Samdani as an Independent Director until April 2031. The meeting concluded with unanimous support for all agenda items.
The passing of resolutions related to financial statements, dividend declaration, and director appointments are routine but important for corporate governance and shareholder returns.
All resolutions, including the declaration of dividend and re-appointment of directors, were passed with the requisite majority, indicating positive shareholder support.
RPG Life Sciences Limited held its Nineteenth Annual General Meeting (AGM) on Thursday, July 23, 2026. The meeting, conducted via Video Conferencing, commenced at 3:00 p.m. IST and concluded at 3:38 p.m. IST. The Chairman, Mr. Harsh V. Goenka, welcomed the members and presented the company's financial performance for the fiscal year 2025-26. All businesses transacted at the AGM, including the adoption of audited standalone and consolidated financial statements for FY 2025-26, the declaration of a dividend of ₹24/- (300%) per equity share, the re-appointment of directors Mr. Harsh V. Goenka and Mr. Manoj Maheshwari, the appointment of Dr. Pratit Samdani as an Independent Director for a term of five years from April 29, 2026, to April 28, 2031, and the ratification of remuneration for the Cost Auditors, were passed with the requisite majority. The company provided facilities for both remote e-voting and e-voting during the AGM.
What to do with a filing like this
RPG Life Sciences Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by RPG Life Sciences Limited. Read the original for the full detail.